Abstract
Ischemic stroke (IS) is one of the main causes of fatal income and disability in most developed countries. Disability due to IS is primarily caused by motor (paresis, ataxia), cognitive and emotional disorders. Post-stroke depression and dementia are associated not only with low compliance to rehabilitation measures and their low efficacy, but also with an increased risk of repeated episodes of acute brain and coronary ischemia, and mortality from cardiovascular diseases. Correction of post-stroke disorders is a complex process; its effectiveness is ensured by timely detection of disorders, early treatment onset, and combined use of medications and non-medications. The article discusses methods to the treatment of patients who have experienced IS, receiving choline alfoscerate. The results of drug administration in both acute and longterm IS were analyzed. Improvement of motor, cognitive and emotional functions was noted. Good tolerability of the drug and the possibility of its simultaneous use with other drugs were emphasized. KEYWORDS: ischemic stroke, post-stroke depression, post-stroke cognitive impairment, hemiparesis, neurometabolic drugs, choline alfoscerate, treatment, rehabilitation. FOR CITATION: Chugunov A.V., Pyshkina L.I., Osmayeva Z.Kh. Correction of post-stroke cognitive and motor disorders. Russian Medical Inquiry. 2020;4(9):584–589. DOI: 10.32364/2587-6821-2020-4-9-584-589.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
